Literature DB >> 14747276

Chronic sympathetic activation: consequence and cause of age-associated obesity?

Douglas R Seals1, Christopher Bell.   

Abstract

Primary aging in adult humans is associated with a progressive, tonic activation of the peripheral sympathetic nervous system (SNS). The purpose of this SNS activation and its physiological impact are, however, unknown. We hypothesize that the chronic stimulation of the SNS with aging is driven in part by a progressive accumulation of body fat. This "error" is sensed by the central nervous system via increases in adiposity-sensitive humoral signals (e.g., leptin, insulin) that cross the blood-brain barrier, activate subcortical areas involved in the regulation of energy balance (e.g., ventromedial hypothalamus), and stimulate SNS outflow to peripheral tissues. The SNS activation is intended to increase beta-adrenergic thermogenesis in order to expend excess energy as heat rather than by storage of fat. Recent evidence, however, indicates that these adjustments are not effective in augmenting energy expenditure with aging. Indeed, older sedentary adults demonstrate reduced, not increased, beta-adrenergic stimulation of metabolic rate because of reduced tissue responsiveness, presumably mediated by SNS-induced impairment of beta-adrenergic signaling. As a result, age-associated SNS activation, initiated as a consequence of accumulating adiposity with the intent of preventing further fat storage, ironically, may in time evolve into a potential mechanism contributing to the development of obesity with aging.

Entities:  

Mesh:

Year:  2004        PMID: 14747276     DOI: 10.2337/diabetes.53.2.276

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  43 in total

Review 1.  Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.

Authors:  Priya Balasubramanian; Delton Hall; Madhan Subramanian
Journal:  Geroscience       Date:  2018-12-05       Impact factor: 7.713

2.  Obesity and catecholamine responses to maximal exercise in adolescent girls.

Authors:  H Zouhal; G Jabbour; H Youssef; A Flaa; E Moussa; C Groussard; C Jacob
Journal:  Eur J Appl Physiol       Date:  2010-05-08       Impact factor: 3.078

3.  Acute sex hormone suppression reduces skeletal muscle sympathetic nerve activity.

Authors:  Danielle S Day; Wendolyn S Gozansky; Christopher Bell; Wendy M Kohrt
Journal:  Clin Auton Res       Date:  2011-06-03       Impact factor: 4.435

Review 4.  Animal aging and regulation of sympathetic nerve discharge.

Authors:  Michael J Kenney
Journal:  J Appl Physiol (1985)       Date:  2010-07-22

5.  Potential role of TCF7L2 gene variants on cardiac sympathetic/parasympathetic activity.

Authors:  Virginia Boccardi; Immacolata Ambrosino; Michela Papa; Daniela Fiore; Maria Rosaria Rizzo; Giuseppe Paolisso; Michelangela Barbieri
Journal:  Eur J Hum Genet       Date:  2010-07-21       Impact factor: 4.246

Review 6.  Interactions of metabolic hormones, adipose tissue and exercise.

Authors:  Robert G McMurray; Anthony C Hackney
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 7.  Views from within and beyond: narratives of cardiac contractile dysfunction under senescence.

Authors:  Xiaoping Yang; Nair Sreejayan; Jun Ren
Journal:  Endocrine       Date:  2005-03       Impact factor: 3.633

8.  Age, weight and sex-hormones.

Authors:  Giris Jacob
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

9.  Does aging alter the molecular substrate of ionotropic neurotransmitter receptors in the rostral ventral lateral medulla? - A short communication.

Authors:  Hitesh N Pawar; Sivasai Balivada; Michael J Kenney
Journal:  Exp Gerontol       Date:  2017-03-02       Impact factor: 4.032

10.  Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases.

Authors:  Hee Yun Suk; Chen Zhou; Teddy T C Yang; Hong Zhu; Raymond Y L Yu; Opeyemi Olabisi; XiaoYong Yang; Deborah Brancho; Ja-Young Kim; Philipp E Scherer; Philippe G Frank; Michael P Lisanti; John W Calvert; David J Lefer; Jeffery D Molkentin; Alessandra Ghigo; Emilio Hirsch; Jianping Jin; Chi-Wing Chow
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.